120 related articles for article (PubMed ID: 7906255)
1. Modulation of cytostatic drugs by nifedipine in two heterotransplanted human testicular-cancer cell lines differing in their sensitivity to standard agents.
Bokemeyer C; Dunn T; Harstrick A; Lerch T; Poliwoda H; Schmoll HJ
Int J Cancer; 1994 Feb; 56(3):452-6. PubMed ID: 7906255
[TBL] [Abstract][Full Text] [Related]
2. Activity of cytostatic drugs in two heterotransplanted human testicular cancer cell lines with different sensitivity to standard agents.
Harstrick A; Schmoll HJ; Casper J; Wilke H; Poliwoda H
Eur J Cancer; 1990; 26(8):898-901. PubMed ID: 2145935
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumour activities of a new benzo[c]phenanthridine agent, 2,3-(methylenedioxy)-5-methyl-7-hydroxy-8-methoxybenzo[c]phena nthridini um hydrogensulphate dihydrate (NK109), against several drug-resistant human tumour cell lines.
Kanzawa F; Nishio K; Ishida T; Fukuda M; Kurokawa H; Fukumoto H; Nomoto Y; Fukuoka K; Bojanowski K; Saijo N
Br J Cancer; 1997; 76(5):571-81. PubMed ID: 9303354
[TBL] [Abstract][Full Text] [Related]
4. Growth and chemotherapy of a human germ-cell tumour line (GCT 27).
Schlappack OK; Bush C; Delic JI; Steel GG
Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535
[No Abstract] [Full Text] [Related]
5. Comparative antitumour activity of cisplatin and two new cisplatin-analogues JM8 and JM9 in human testicular carcinoma xenografts.
Harstrick A; Casper J; Schmoll HJ
Int J Androl; 1987 Feb; 10(1):139-45. PubMed ID: 3034790
[TBL] [Abstract][Full Text] [Related]
6. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
7. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.
Dantzig AH; Shepard RL; Cao J; Law KL; Ehlhardt WJ; Baughman TM; Bumol TF; Starling JJ
Cancer Res; 1996 Sep; 56(18):4171-9. PubMed ID: 8797588
[TBL] [Abstract][Full Text] [Related]
8. Comparative activity of four anthracyclines against heterotransplanted germ cell tumor lines.
Harstrick A; Casper J; Köhne-Wömpner H; Wilke H; Schmoll HJ; Poliwoda H
Invest New Drugs; 1990; 8 Suppl 1():S19-24. PubMed ID: 1696245
[TBL] [Abstract][Full Text] [Related]
9. The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna.
Bokemeyer C; Schmoll HJ; Ludwig E; Harstrick A; Dunn T; Casper J
Br J Cancer; 1994 May; 69(5):863-7. PubMed ID: 8180015
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
Fuchs J; Wenderoth M; von Schweinitz D; Haindl J; Leuschner I
Cancer; 1998 Dec; 83(11):2400-7. PubMed ID: 9840541
[TBL] [Abstract][Full Text] [Related]
11. Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma.
Naito S; Sakamoto N; Kotoh S; Goto K; Matsumoto T; Kumazawa J
Eur Urol; 1993; 24(1):156-60. PubMed ID: 8103456
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro.
Hill BT; van der Graaf WT; Hosking LK; de Vries EG; Mulder NH; Whelan RD
Int J Cancer; 1993 Sep; 55(2):330-7. PubMed ID: 8103761
[TBL] [Abstract][Full Text] [Related]
14. Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposide.
Asano T; Zwelling LA; An T; McWatters A; Herzog CE; Mayes J; Loughlin SM; Kleinerman ES
Br J Cancer; 1996 Jun; 73(11):1373-80. PubMed ID: 8645582
[TBL] [Abstract][Full Text] [Related]
15. Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro.
Licht T; Fiebig HH; Bross KJ; Herrmann F; Berger DP; Shoemaker R; Mertelsmann R
Int J Cancer; 1991 Oct; 49(4):630-7. PubMed ID: 1917165
[TBL] [Abstract][Full Text] [Related]
16. In vivo modulation of cisplatin cytotoxicity by the cholecystokinin antagonist MK-329 in human pancreatic cancer xenografts.
Jamshidipour R; Pinho EB; Howell SB
Anticancer Res; 1994; 14(6B):2611-6. PubMed ID: 7872689
[TBL] [Abstract][Full Text] [Related]
17. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody.
Mechetner EB; Roninson IB
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5824-8. PubMed ID: 1352877
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents.
Mickley LA; Bates SE; Richert ND; Currier S; Tanaka S; Foss F; Rosen N; Fojo AT
J Biol Chem; 1989 Oct; 264(30):18031-40. PubMed ID: 2572588
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenografts.
Dunn TA; Grünwald V; Bokemeyer C; Casper J
Invest New Drugs; 1997; 15(2):91-8. PubMed ID: 9220287
[TBL] [Abstract][Full Text] [Related]
20. Efficient carboplatin single therapy in a mouse model of human testicular nonseminomatous germ cell tumor.
Aharinejad S; Fink M; Abri H; Nedwed S; Schlag MG; Macfelda K; Abraham D; Miksovsky A; Höltl E; Höltl W
J Urol; 2002 Jan; 167(1):368-74. PubMed ID: 11743358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]